scholarly article | Q13442814 |
P819 | ADS bibcode | 2018NatCo...9.2397K |
P6179 | Dimensions Publication ID | 1104585023 |
P356 | DOI | 10.1038/S41467-018-04732-5 |
P932 | PMC publication ID | 6008330 |
P698 | PubMed publication ID | 29921915 |
P50 | author | Kári Stefánsson | Q6453246 |
Carsten Oliver Schmidt | Q20748664 | ||
Frauke Zipp | Q21259942 | ||
Heinz Wiendl | Q27583547 | ||
Sigurgeir Olafsson | Q88246221 | ||
Ewoud Ewing | Q88377522 | ||
Hannes P Eggertsson | Q89067127 | ||
Elisabeth Gulowsen Celius | Q89585276 | ||
Bernhard Hemmer | Q89705523 | ||
Hanne F Harbo | Q90089338 | ||
Maja Jagodic | Q90585165 | ||
Tomas J Ekström | Q91345092 | ||
Lara Kular | Q91863056 | ||
Ralf Gold | Q99630149 | ||
Tomas Olsson | Q100512112 | ||
Annette B Oturai | Q114403567 | ||
Helle Bach Søndergaard | Q114403573 | ||
Sabrina Ruhrmann | Q114529274 | ||
Tojo James | Q114529279 | ||
Shahin Aeinehband | Q114529283 | ||
Haukur Hjaltason | Q117242197 | ||
Tim Kacprowski | Q37634569 | ||
Andre Franke | Q67470670 | ||
Jenny Link | Q55314033 | ||
Magdalena Lindén | Q55446213 | ||
Ingrid Kockum | Q55446225 | ||
Till F.M. Andlauer | Q56356067 | ||
Fredrik Piehl | Q56956300 | ||
Alexander Dilthey | Q57451433 | ||
David Gomez-Cabrero | Q40263865 | ||
Yun Liu | Q41882741 | ||
Francesco Marabita | Q42830707 | ||
Andrew P. Feinberg | Q47421545 | ||
Bjarni V. Halldórsson | Q47502536 | ||
Björn Tackenberg | Q48239917 | ||
Pernilla Stridh | Q48590093 | ||
P2093 | author name string | Matthias Laudes | |
Jesper Tegnér | |||
Konstantin Strauch | |||
Frank Weber | |||
Ingileif Jonsdottir | |||
Rajesh Rawal | |||
Ulf Schminke | |||
Bartosz Górnikiewicz | |||
Christiane Gasperi | |||
Stefanie Heilmann-Heimbach | |||
Elias Olafsson | |||
Galina Zheleznyakova | |||
P2860 | cites work | The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions | Q24312117 |
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans | Q24533132 | ||
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis | Q24635370 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing | Q28249503 | ||
Genetic and epigenetic fine mapping of causal autoimmune disease variants | Q28649603 | ||
Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations | Q28732826 | ||
Disentangling molecular relationships with a causal inference test | Q28742231 | ||
[DHS: The Dortmund health study] | Q84465416 | ||
Development of monocytes, macrophages, and dendritic cells | Q29616446 | ||
limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses | Q30504688 | ||
DNA methylation arrays as surrogate measures of cell mixture distribution | Q30530775 | ||
Modelling genetic susceptibility to multiple sclerosis with family data. | Q30573802 | ||
Differential roles of microglia and monocytes in the inflamed central nervous system | Q30585165 | ||
An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene | Q33405616 | ||
Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop | Q33556144 | ||
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays | Q33593399 | ||
Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. | Q33839575 | ||
Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance | Q34112986 | ||
Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets | Q34464568 | ||
Large-scale whole-genome sequencing of the Icelandic population | Q34468572 | ||
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis | Q34555143 | ||
Multi-population classical HLA type imputation | Q34607788 | ||
Detection of sharing by descent, long-range phasing and haplotype imputation | Q34928818 | ||
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. | Q34986752 | ||
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer | Q35029543 | ||
Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children | Q35120318 | ||
Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis | Q35143918 | ||
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans | Q35536380 | ||
Filter-free exhaustive odds ratio-based genome-wide interaction approach pinpoints evidence for interaction in the HLA region in psoriasis | Q35555915 | ||
The sva package for removing batch effects and other unwanted variation in high-throughput experiments | Q35838453 | ||
Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals | Q36089373 | ||
KORA--a research platform for population based health research | Q36201201 | ||
Differential expression of major histocompatibility complex class II genes on murine macrophages associated with T cell cytokine profile and protective/suppressive effects. | Q36500075 | ||
TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing | Q36543721 | ||
Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation | Q36891490 | ||
Class II HLA interactions modulate genetic risk for multiple sclerosis | Q36920509 | ||
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation | Q37056269 | ||
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis | Q37322100 | ||
Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells | Q37429886 | ||
Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains | Q37602769 | ||
High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model | Q57704203 | ||
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation | Q67522337 | ||
Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles | Q72417150 | ||
The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients | Q78104025 | ||
The interleukin 23 receptor gene in multiple sclerosis: a case-control study | Q80420894 | ||
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. | Q50515193 | ||
The Swedish Twin Registry: establishment of a biobank and other recent developments. | Q51302187 | ||
HLA-DRB1*15:01 and multiple sclerosis: a female association? | Q51381791 | ||
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. | Q51517678 | ||
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis. | Q53099338 | ||
HL-A antigens and multiple sclerosis. | Q53892212 | ||
Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis. | Q54443135 | ||
Common and Low-Frequency Genetic Variants in the PCSK9 Locus Influence Circulating PCSK9 Levels | Q57303401 | ||
Cohort Profile: The Study of Health in Pomerania | Q57429582 | ||
GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease | Q37693372 | ||
The insulator protein CTCF represses transcription on binding to the (gt)(22)(ga)(15) microsatellite in intron 2 of the HLA-DRB1(*)0401 gene | Q38309421 | ||
Function and information content of DNA methylation | Q38319920 | ||
Epigenetic research in multiple sclerosis: progress, challenges, and opportunities. | Q38654321 | ||
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets | Q38685035 | ||
Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study. | Q39454014 | ||
DNA methylation: bisulphite modification and analysis. | Q39479194 | ||
DNA methylation dysregulates and silences the HLA-DQ locus by altering chromatin architecture | Q39591021 | ||
Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Facto | Q39611593 | ||
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression | Q40862437 | ||
The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele | Q41287692 | ||
An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform | Q41313805 | ||
HIBAG--HLA genotype imputation with attribute bagging. | Q42614757 | ||
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis | Q43282863 | ||
Nicotine might have a protective effect in the etiology of multiple sclerosis. | Q45954074 | ||
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis | Q46889094 | ||
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations | Q47105714 | ||
Orienting the causal relationship between imprecisely measured traits using GWAS summary data | Q47142527 | ||
Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients | Q47564983 | ||
Graphtyper enables population-scale genotyping using pangenome graphs. | Q47637069 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA methylation | Q874745 |
multiple sclerosis | Q8277 | ||
P304 | page(s) | 2397 | |
P577 | publication date | 2018-06-19 | |
P1433 | published in | Nature Communications | Q573880 |
P1476 | title | DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis | |
P478 | volume | 9 |
Q62924311 | Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing⁻Remitting Multiple Sclerosis |
Q64109660 | Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression |
Q64064150 | DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis |
Q92725655 | Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions |
Q92492014 | Environmental and genetic risk factors for MS: an integrated review |
Q89936636 | Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders |
Q92476184 | Frameshift mutations at the C-terminus of HIST1H1E result in a specific DNA hypomethylation signature |
Q64083696 | Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome |
Q91345098 | Genotype-dependent epigenetic regulation of DLGAP2 in alcohol use and dependence |
Q102144616 | Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning |
Q96304273 | Multiple Sclerosis: Lipids, Lymphocytes, and Vitamin D |
Q64062056 | Quantitative proteomic analyses of CD4 and CD8 T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls |
Q61818118 | The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis |
Q90754651 | Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein-Barr Virus hypomethylated regions |
Q64109951 | pwrEWAS: a user-friendly tool for comprehensive power estimation for epigenome wide association studies (EWAS) |
Search more.